NO841540L - Fremgangsmaate ved fremstilling av bredspektrede influensaantisera - Google Patents

Fremgangsmaate ved fremstilling av bredspektrede influensaantisera

Info

Publication number
NO841540L
NO841540L NO841540A NO841540A NO841540L NO 841540 L NO841540 L NO 841540L NO 841540 A NO841540 A NO 841540A NO 841540 A NO841540 A NO 841540A NO 841540 L NO841540 L NO 841540L
Authority
NO
Norway
Prior art keywords
influense
antization
procedure
specific
manufacturing wide
Prior art date
Application number
NO841540A
Other languages
English (en)
Other versions
NO161002C (no
NO161002B (no
Inventor
Nicola Green
Stephen Alexander
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of NO841540L publication Critical patent/NO841540L/no
Publication of NO161002B publication Critical patent/NO161002B/no
Publication of NO161002C publication Critical patent/NO161002C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO841540A 1982-08-23 1984-04-17 Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider. NO161002C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41045582A 1982-08-23 1982-08-23
PCT/US1983/001291 WO1984000687A1 (en) 1982-08-23 1983-08-23 Broad spectrum influenza antisera

Publications (3)

Publication Number Publication Date
NO841540L true NO841540L (no) 1984-04-17
NO161002B NO161002B (no) 1989-03-13
NO161002C NO161002C (no) 1989-06-21

Family

ID=23624803

Family Applications (1)

Application Number Title Priority Date Filing Date
NO841540A NO161002C (no) 1982-08-23 1984-04-17 Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider.

Country Status (16)

Country Link
EP (1) EP0116629A4 (no)
JP (1) JPS59501714A (no)
KR (1) KR840006198A (no)
AU (1) AU570929B2 (no)
DK (1) DK203684A (no)
ES (1) ES525088A0 (no)
FI (1) FI841583A0 (no)
GR (1) GR78931B (no)
IL (1) IL69556A (no)
IT (1) IT1168636B (no)
NO (1) NO161002C (no)
NZ (2) NZ220612A (no)
PH (1) PH18872A (no)
PT (1) PT77230B (no)
WO (1) WO1984000687A1 (no)
ZA (1) ZA836080B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR241713A1 (es) * 1984-08-30 1992-11-30 Smithkline Beckman Corp Molecula de dna con una secuencia de bases que codifica la proteina c13 y preparacion de vacunas contra la gripe.
US5866363A (en) 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
AU4948890A (en) * 1989-01-12 1990-08-13 Blood Center Of Southeastern Wisconsin, The Peptide-mediated modulation of t-cell recognition as a means of affecting immune responses
EP0621339B1 (en) * 1992-09-17 2001-10-24 Takara Shuzo Co. Ltd. Immunogenic human influenza A virus haemagglutinin polypeptides
JP2996864B2 (ja) * 1994-03-30 2000-01-11 寳酒造株式会社 抗体可変領域ｄｎａ
US8148085B2 (en) 2006-05-15 2012-04-03 Sea Lane Biotechnologies, Llc Donor specific antibody libraries
US20080014205A1 (en) * 2006-05-15 2008-01-17 Lawrence Horowitz Neutralizing Antibodies to Influenza Viruses
WO2008028946A2 (en) * 2006-09-07 2008-03-13 Crucell Holland B.V. Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
ITTO20070066A1 (it) 2007-01-30 2008-07-31 Pomona Biotechnologies Llc Anticorpi monoclonali anti-idiotipo mimotopi dell'antigene gp 120 di hiv
JP5779350B2 (ja) 2007-03-27 2015-09-16 シー レーン バイオテクノロジーズ， エルエルシー 抗体代替軽鎖配列を含む構築物およびライブラリー
ITTO20080204A1 (it) 2008-03-17 2009-09-18 Pomona Biotechnologies Llc Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
AU2009228058A1 (en) 2008-03-28 2009-10-01 Sea Lane Biotechnologies, Llc Neutralizing molecules to viral antigens
ITTO20080398A1 (it) 2008-05-27 2009-11-28 Pomona Biotechnologies Llc Anticorpi monoclonali aventi proprieta' di cross-neutralizzazione omosubtipica per virus influenzali di tipo a sottotipo h1
ITTO20080964A1 (it) 2008-12-22 2010-06-23 Natimab Therapeutics S R L Anticorpo monoclonale anti-hcv come medicamento per il trattamento terapeutico e la prevenzione di infezioni da hcv
US8975378B2 (en) 2008-12-25 2015-03-10 Osaka University Human anti-human influenza virus antibody
EP2413962A1 (en) 2009-03-30 2012-02-08 Mount Sinai School of Medicine Influenza virus vaccines and uses thereof
CN102482345A (zh) * 2009-05-13 2012-05-30 航道生物技术有限责任公司 针对流感病毒的中和分子
AU2010254136B2 (en) 2009-05-26 2016-09-29 Mount Sinai School Of Medicine Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
IT1395961B1 (it) * 2009-06-01 2012-11-02 Pomona Biotechnologies Llc Anticorpi monoclonali come medicamento per il trattamento terapeutico e/o profilattico delle infezioni da virus influenzale a (h1n1) di origine suina (s-oiv)
EP2536425B1 (en) * 2010-02-18 2019-06-19 Icahn School of Medicine at Mount Sinai Vaccines for use in the prophylaxis and treatment of influenza virus disease
KR20130075732A (ko) 2010-03-30 2013-07-05 마운트 시나이 스쿨 오브 메디슨 인플루엔자 바이러스 백신 및 이의 용도
CA2842860A1 (en) 2011-07-28 2013-01-31 Sea Lane Biotechnologies, Llc Sur-binding proteins
EP2758075B1 (en) 2011-09-20 2023-05-03 Icahn School of Medicine at Mount Sinai Influenza virus vaccines and uses thereof
ES2710916T3 (es) 2011-12-22 2019-04-29 I2 Pharmaceuticals Inc Proteínas de unión sustitutas
US9969794B2 (en) 2012-05-10 2018-05-15 Visterra, Inc. HA binding agents
AU2013362935B2 (en) 2012-12-18 2018-10-04 Icahn School Of Medicine At Mount Sinai Influenza virus vaccines and uses thereof
WO2014159960A1 (en) 2013-03-14 2014-10-02 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
US10736956B2 (en) 2015-01-23 2020-08-11 Icahn School Of Medicine At Mount Sinai Influenza virus vaccination regimens
WO2017083627A1 (en) 2015-11-13 2017-05-18 Visterra, Inc. Compositions and methods for treating and preventing influenza
WO2017218624A1 (en) 2016-06-15 2017-12-21 Icahn School Of Medicine At Mount Sinai Influenza virus hemagglutinin proteins and uses thereof
US11254733B2 (en) 2017-04-07 2022-02-22 Icahn School Of Medicine At Mount Sinai Anti-influenza B virus neuraminidase antibodies and uses thereof
AU2020248404A1 (en) 2019-03-25 2021-09-30 Visterra, Inc. Compositions and methods for treating and preventing influenza

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63224A (en) * 1980-07-17 1985-05-31 Scripps Clinic Res Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom

Also Published As

Publication number Publication date
AU1947183A (en) 1984-03-07
JPS59501714A (ja) 1984-10-11
NZ205341A (en) 1988-07-28
AU570929B2 (en) 1988-03-31
FI841583A (fi) 1984-04-19
EP0116629A1 (en) 1984-08-29
PT77230A (en) 1983-09-01
ZA836080B (en) 1984-04-25
ES8505819A1 (es) 1985-06-16
IL69556A0 (en) 1983-11-30
IT1168636B (it) 1987-05-20
PH18872A (en) 1985-10-21
PT77230B (en) 1986-02-04
ES525088A0 (es) 1985-06-16
NO161002C (no) 1989-06-21
GR78931B (no) 1984-10-02
WO1984000687A1 (en) 1984-03-01
IL69556A (en) 1988-05-31
KR840006198A (ko) 1984-11-22
DK203684D0 (da) 1984-04-18
DK203684A (da) 1984-04-18
EP0116629A4 (en) 1987-06-29
IT8348868A0 (it) 1983-08-22
NZ220612A (en) 1988-07-28
FI841583A0 (fi) 1984-04-19
NO161002B (no) 1989-03-13

Similar Documents

Publication Publication Date Title
NO841540L (no) Fremgangsmaate ved fremstilling av bredspektrede influensaantisera
NO812977L (no) Fremgangsmaate for fremstilling av mikrokapsler
NO810506L (no) Fremgangsmaate ved fremstilling av polytetrafluoretylengjenstander
NO820222L (no) Fremgangsmaate for fremstilling av aromatiske uretaner
NO811330L (no) Fremgangsmaate ved fremstilling av mikroemulsjoner
NO792267L (no) Fremgangsmaate ved fremstilling av substituerte benzapiner
NO833914L (no) Fremgangsmaate ved fremstilling av hjul
NO813863L (no) Fremgangsmaate ved toerking av trevirke
NO154602C (no) Fremgangsmaate ved opparbeiding av vrakglass.
NO834661L (no) Fremgangsmaate ved fremstilling av modellis
NO831495L (no) Fremgangsmaate ved fremstilling av sulfatmasse
DK156099C (da) Fremgangsmaade ved fremkaldelse
NO810695L (no) Fremgangsmaate ved fremstilling av sementklinker.
NO831607L (no) Fremgangsmaate ved fremstilling av sponplater
NO830784L (no) Fremgangsmaate for fremstilling av tioetere
NO834407L (no) Fremgangsmaate ved delignifiserende bleking av cellulosemasse
FI831883L (fi) Process foer tillverkning av aromatiska polyestrar
NO150515C (no) Fremgangsmaate ved fremstilling av 5`-deoxy-5`-methylthioadenosin
NO802983L (no) Fremgangsmaate ved fremstilling av krympeartikler
FI833868A0 (fi) Anordning foer daempning av en slagbelastning
NO831445L (no) Fremgangsmaate for deemulgering ved hjelp av ammonium-polyamidoaminer
NO822485L (no) Fremgangsmaate ved fremstilling av bisykliske forbindelser
FI831814A0 (fi) Anordning foer bearbetning av traedbark
FI831781L (fi) Process foer portionsvis kokning av traeflis
NO833669L (no) Fremgangsmaate for elektroplettering